High prevalence of undiagnosed COPD in a cohort of HIV-infected smokers

European Respiratory Journal

Volumn 45, Issue 3, 2015, Pages 828-831

  Makinson, Alain ^a,c   Hayot, Maurice ^a   Eymard Duvernay, Sabrina ^b   Quesnoy, Mylène ^b   Raffi, François ^d   Thirard, Laurence ^e   Bonnet, Fabrice ^f   Tattevin, Pierre ^g   Abgrall, Sophie ^h   Quantin, Xavier ^a   Léna, Hervé ^g   Bommart, Sébastien ^a   Reynes, Jacques ^a,b   Le Moing, Vincent ^a,b  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c Clinique Beau Soleil   (France)

^d ANRS   (France)

^e University Hospital of Tourcoing   (France)

^f BORDEAUX UNIVERSITY HOSPITAL   (France)

^g PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^h Tropical and Infectious Diseases Department   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE;

ADULT; AGE; ARTICLE; BODY MASS; CANNABIS USE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FRANCE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; PLETHYSMOGRAPHY; PNEUMOCYSTIS PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; RESIDUAL VOLUME; SEX; SMOKING; SPIROMETRY; TOTAL LUNG CAPACITY; ADVERSE EFFECTS; COMPLICATION; HIV INFECTIONS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 84924010503     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00154914     Document Type: Article

References (17)

1. Crothers K, Huang L, Goulet JL, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 2010; 183: 388-395.
2. Madeddu G, Fois AG, Calia GM, et al. Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? Infection 2012; 41: 347-353.
3. Samperiz G, Guerrero D, Lopez M, et al. Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapy. HIV Med 2014; 15: 321-329.
4. George MP, Kannass M, Huang L, et al. Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era. PLoS One 2009; 4: e6328
5. Drummond MB, Kirk GD, Astemborski J, et al. Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax 2012; 67: 309-314.
6. Morris A, Alexander T, Radhi S, et al. Airway obstruction is increased in pneumocystis-colonized human immunodeficiency virus-infected outpatients. J Clin Microbiol 2009; 47: 3773-3776.
7. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720-735.
8. Standardized lung function testing. Official statement of the European Respiratory Society. Eur Respir J 1993; 6 Suppl. 16:1-100.
9. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. www.goldcopd.org/uploads/users/files/GOLD-Report-2014- Jun11.pdf Date last updated: June 11, 2014.
10. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40: 1324-1343.
11. Quanjer PH, Enright PL, Miller MR, et al. The need to change the method for defining mild airway obstruction. Eur Respir J 2011; 37: 720-722.
12. Buist AS, Vollmer WM, McBurnie MA. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative. Int J Tuberc Lung Dis 2008; 12: 703-708.
13. Hill K, Goldstein RS, Guyatt GH, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ 2010; 182: 673-678.
14. Tashkin DP. Effects of marijuana smoking on the lung. Ann Am Thorac Soc 2013; 10: 239-247.
15. Fischer WA II, Drummond MB, Merlo CA, et al. Hepatitis C virus infection is not an independent risk factor for obstructive lung disease. COPD 2014; 11: 10-16.
16. Crothers K, McGinnis K, Kleerup E, et al. HIV infection is associated with reduced pulmonary diffusing capacity. J Acquir Immune Defic Syndr 2013; 64: 271-278.
17. Gingo MR, He J, Wittman C, et al. Contributors to diffusion impairment in HIV-infected persons. Eur Respir J 2013; 43: 195-203.